Alputon Inc. ( China (Mainland))

Alputon Inc. is a pharmaceutical R&D service company which provides services to global pharmaceutical and biotech industries with its initial focus in chemistry such as 6-Aminomethylquinoline with CAS registry number of 99071-54-2. It was founded at the Zhangjiang Hi-Tech Park, Shanghai, China, in April 2007 by a team of highly accomplished scientists and managers with over ten years work experiences in pharmaceutical and biotech industries in USA.

Alputon Inc. owns many advantages. It owns a highly experienced scientific and managerial team with proven track records in drug discovery to manage customer's programs to which the international standards of IP protection, work ethics, business conduct are applied. Secondly, the state of the art parallel synthesis and purification technology platform(eI2C) acquired from ArQule, coupled with highly competent traditional organic and medicinal chemistry skill sets, provides unique capabilities, capacity and speed in discovery chemistry for customer's programs. In addition, Alputon also owns the customer-focused company culture and western-type management style.

Alputon could advance customer's programs such as hit generation, hit follow-up and expansion, and lead optimization as well as design and synthesis of templates and libraries, better, faster and cheaper.